Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)

CUSIP: 207523101

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 6 signals
Share change
-3,171,497
SEC-reported price per share
$1.74
Number of holders
11
Value change
-$3,787,306
Number of buys
2
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
63,008,975

Security key

207523101

Report period

Q1 2024

Institutions

11

Top holders

10

Ownership snapshot

Top reported holders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/14
Latest evidence
31 Dec 2023
13F Highest disclosed value: $3,614,188 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $3.61M.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
RA CAPITAL MANAGEMENT, L.P. $3.61M
BML Capital Management, LLC $2.43M
BlackRock Finance, Inc. $1.23M
OCONNOR, A Distinct Business Unit... $662.2K
RENAISSANCE TECHNOLOGIES LLC $352K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$3,614,188
3,062,871 shares
— 31 Dec 2023
BML Capital Management, LLC
13F
Company
13F
—
denominator unverified
$2,432,497
2,061,438 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$1,227,279
1,040,067 shares
— 31 Dec 2023
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
13F
—
denominator unverified
$662,205
561,191 shares
— 31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$352,000
298,000 shares
— 31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$32,993
27,961 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
11
Shares
3,947,159
Rows available
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q1 2024 holders
11
Holder diff
10
Investor Q1 2026 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2026 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .